Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study

Turner, M.R, Cagnin, A, Turkheimer, F.E, Miller, C.C.J, Shaw, C.E, Brooks, D.J, Leigh, P.N, Banati, R.B·2004·Neurobiology of Disease

Cited by (737)

Items 101–200 of 737

  1. Evidence for astrocytosis in ALS demonstrated by [11C](l)-deprenyl-D2 PET
    Anders Johansson, Henry Engler, Gunnar Blomquist, Berit Scott, Anders E. Wall, Sten‐Magnus Aquilonius, Bengt Långström, Håkan Askmark · 2007 · Journal of the Neurological Sciences
  2. Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis
    Thompson, Alexander G., Gray, Elizabeth, Thézénas, Marie‐Laëtitia, Charles, Philip D., Evetts, Samuel, Hu, Michele T., Talbot, Kevin, Fischer, Roman, Kessler, Benedikt M., Turner, Martin R. · 2018 · Annals of Neurology
  3. Microglia as a Pharmacological Target in Infectious and Inflammatory Diseases of the Brain
    Robert Bryan Rock, Phillip K. Peterson · 2006 · Journal of Neuroimmune Pharmacology
  4. Biomarkers in Motor Neuron Disease: A State of the Art Review
    Nick S. Verber, Stephanie R. Shepheard, Matilde Sassani, Harry E. McDonough, Sophie A. Moore, James J. P. Alix, Iain David Wilkinson, Thomas Michael Jenkins, Pamela J. Shaw · 2019 · Frontiers in Neurology
  5. The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients
    Cistaro, Angelina, Pagani, Marco, Montuschi, Anna, Calvo, Andrea, Moglia, Cristina, Canosa, Antonio, Restagno, Gabriella, Brunetti, Maura, Traynor, Bryan J., Nobili, Flavio et al. · 2014 · European Journal of Nuclear Medicine and Molecular Imaging
  6. Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study
    Versijpt, J, Debruyne, J C, Van Laere, K J, De Vos, F, Keppens, J, Strijckmans, K, Achten, E, Slegers, G, Dierckx, R A, Korf, J et al. · 2005 · Multiple Sclerosis Journal
  7. Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis
    Mengmeng Jin, René Günther, Katja Akgün, Andreas Hermann, Tjalf Ziemssen · 2020 · Scientific Reports
  8. Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses
    Béland, Louis-Charles, Markovinovic, Andrea, Jakovac, Hrvoje, De Marchi, Fabiola, Bilic, Ervina, Mazzini, Letizia, Kriz, Jasna, Munitic, Ivana · 2020 · Brain Communications
  9. Differential contribution of microglia and monocytes in neurodegenerative diseases
    Caroline Baufeld, Elaine K. O'Loughlin, Narghes Calcagno, Charlotte Madore, Oleg Butovsky · 2017 · Journal of Neural Transmission
  10. Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis
    Steve Vucic, Matthew C. Kiernan · 2007 · Journal of Neurology Neurosurgery & Psychiatry
  11. Inhibitors of Microglial Neurotoxicity: Focus on Natural Products
    Dong‐Kug Choi, Sushruta Koppula, Kyoungho Suk · 2011 · Molecules
  12. Sensorimotor Functional Connectivity Changes in Amyotrophic Lateral Sclerosis
    Federica Agosta, Paola Valsasina, Martina Absinta, Nilo Riva, Stefania Sala, Alessandro Cesare Prelle, Massimiliano Copetti, Mauro Comola, Gıancarlo Comı, Massimo Filippi · 2011 · Cerebral Cortex
  13. Viruses and neurodegeneration
    Li Zhou, Monica Miranda Saksena, Nitin K. Saksena · 2013 · Virology Journal
  14. The Positron Emission Tomography Ligand DAA1106 Binds With High Affinity to Activated Microglia in Human Neurological Disorders
    Sriram Venneti, Guoji Wang, Jason Nguyen, Clayton A. Wiley · 2008 · Journal of Neuropathology & Experimental Neurology
  15. Expression of Amyotrophic Lateral Sclerosis-linked SOD1 Mutant Increases the Neurotoxic Potential of Microglia via TLR2
    Yang Liu, Wenlin Hao, Alik Dawson, Shirong Liu, Klaus C Fassbender · 2008 · Journal of Biological Chemistry
  16. Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma
    Toth, Reka P., Atkin, Julie D. · 2018 · Frontiers in Immunology
  17. Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS
    Dima A. Hammoud, Christopher J. Endres, Ankit Chander, Tomás R. Guilarte, Dean Foster Wong, Ned C Sacktor, Justin C. McArthur, Martin G. Pomper · 2005 · Journal of NeuroVirology
  18. Translocator Protein 18 kDa Negatively Regulates Inflammation in Microglia
    Keun-Ryung Bae, Hyun-Jung Shim, Deebika Balu, Sang Ryong Kim, Seong‐Woon Yu · 2014 · Journal of Neuroimmune Pharmacology
  19. ALS biomarkers for therapy development: State of the field and future directions
    Michael G Benatar, Khrista Boylan, Andreas Jeromin, Seward B. Rutkove, James D. Berry, Nazem Atassi, Lucie I. Bruijn · 2015 · Muscle & Nerve
  20. Disease-modifying therapies in amyotrophic lateral sclerosis
    Adriano Chiò, Letizia Mazzini, Gabriele Mora · 2020 · Neuropharmacology
  21. 25 years of neuroimaging in amyotrophic lateral sclerosis
    Bradley R. Foerster, Robert C. Welsh, Eva L. Feldman · 2013 · Nature Reviews Neurology
  22. The anatomy of cognitive impairment in amyotrophic lateral sclerosis: More than frontal lobe dysfunction
    Stella K. Tsermentseli, P. Nigel Leigh, Laura H. Goldstein · 2011 · Cortex
  23. Amyotrophic Lateral Sclerosis: A Neurodegenerative Motor Neuron Disease With Ocular Involvement
    Pilar Rojas, Ana Isabel Ramirez, José A. Fernández‐Albarral, Inés López‐Cuenca, Elena Salobrar‐García, Manuel Cadena, Lorena Elvira‐Hurtado, Juan Jose Salazar, Rosa de Hoz, Jose Manuel Ramirez · 2020 · Frontiers in Neuroscience
  24. Glial Cells in Amyotrophic Lateral Sclerosis
    Jurate Lasiene, Koji Yamanaka · 2011 · Neurology Research International
  25. New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases
    Eveljn Scarian, Camilla Viola, Francesca Dragoni, Rosalinda Di Gerlando, Bartolo Rizzo, Luca Diamanti, Stella Gagliardi, Matteo Bordoni, Orietta Pansarasa · 2024 · International Journal of Molecular Sciences
  26. Mast Cells in Neurodegenerative Disease
    Michael K. Jones, Archana A. Nair, Mihir Gupta · 2019 · Frontiers in Cellular Neuroscience
  27. Imaging of translocator protein upregulation is selective for pro‐inflammatory polarized astrocytes and microglia
    Pannell, Maria, Economopoulos, Vasiliki, Wilson, Thomas C., Kersemans, Veerle, Isenegger, Patrick G., Larkin, James R., Smart, Sean, Gilchrist, Stuart, Gouverneur, Véronique, Sibson, Nicola R. · 2020 · Glia
  28. System xC− is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice
    Pinar Mesci, Sakina Zaïdi, Christian S. Lobsiger, Stéphanie Millecamps, Carole Escartin, Danielle Seilhean, Hideyo Sato, Michel Mallat, Séverine Boillée · 2014 · Brain
  29. PET Imaging of the Peripheral Benzodiazepine Receptor: Monitoring Disease Progression and Therapy Response in Neurodegenerative Disorders
    Janine Doorduin, Erik F. J. de Vries, Rudi A. J. O. Dierckx, Hans Klein · 2008 · Current Pharmaceutical Design
  30. The relationship between inflammation, impaired glymphatic system, and neurodegenerative disorders: A vicious cycle
    Yu Cai, Yangqiqi Zhang, Shuo Leng, Yuanyuan Ma, Quan Jiang, Qiuting Wen, Shenghong Ju, Jiani Hu · 2024 · Neurobiology of Disease
  31. Astroglia as a cellular target for neuroprotection and treatment of neuro‐psychiatric disorders
    Beihui Liu, Anja G. Teschemacher, Sergey Kasparov · 2017 · Glia
  32. Translocator protein (TSPO): the new story of the old protein in neuroinflammation
    Young Hwan Lee, Young‐Jin Park, Hyeri Nam, Ji‐Won Lee, Seong‐Woon Yu · 2020 · BMB Reports
  33. The endocannabinoid pathway in Huntington's disease: A comparison with other neurodegenerative diseases
    Mauro Maccarrone, Natalia Battista, Diego Centonze · 2007 · Progress in Neurobiology
  34. CSF chitinase proteins in amyotrophic lateral sclerosis
    Alexander G. Thompson, Elizabeth Gray, Alexander Bampton, Dominika Raciborska, Kevin Talbot, Martin R. Turner · 2019 · Journal of Neurology Neurosurgery & Psychiatry
  35. Nanoparticles: A Hope for the Treatment of Inflammation in CNS
    Feng-Dan Zhu, Yu-Jiao Hu, Lu Yu, Xiao-Gang Zhou, Jian-Ming Wu, Yong Tang, Da-Lian Qin, Qingze Fan, An-Guo Wu · 2021 · Frontiers in Pharmacology
  36. ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression
    Hazel Quek, Carla Cuní‐López, Romal Stewart, Tiziana Colletti, Antonietta Notaro, Yifan Sun, Christine Cong Guo, Michelle K. Lupton, Tam Hong Nguyen, Lotta E. Oikari et al. · 2022 · Journal of Neuroinflammation
  37. [11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS
    Martin R. Turner · 2005 · Brain
  38. Positron emission tomography and single-photon emission computed tomography in central nervous system drug development
    David James Brooks · 2005 · NeuroRx
  39. Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
    Riva, Nilo, Mora, Gabriele, Sorarù, Gianni, Lunetta, Christian, Ferraro, Ottavia E, Falzone, Yuri, Leocani, Letizia, Fazio, Raffaella, Comola, Mauro, Comi, Giancarlo et al. · 2019 · The Lancet Neurology
  40. Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations
    Robert P. Bowser, Martin R. Turner, Jeremy M. Shefner · 2011 · Nature Reviews Neurology
  41. Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype
    Kate Roberts, Rafaa Zeineddine, Lisa Corcoran, Wen Li, Iain Leslie Campbell, Justin J. Yerbury · 2012 · Glia
  42. Transcriptome–pathology correlation identifies interplay between TDP-43 and the expression of its kinase CK1E in sporadic ALS
    Florian Krach, Ranjan Batra, Emily C. Wheeler, Anthony Q. Vu, Ruth Wang, Kasey R. Hutt, Stuart J. Rabin, Michael W. Baughn, Ryan T. Libby, Sandra Díaz-García et al. · 2018 · Acta Neuropathologica
  43. Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis
    Carsten Keil, Tino Prell, Thomas Peschel, Viktor Hartung, Reinhard Dengler, Julian Großkreutz · 2012 · BMC Neuroscience
  44. Activation of the p38MAPK cascade is associated with upregulation of TNF alpha receptors in the spinal motor neurons of mouse models of familial ALS
    Pietro Veglianese, Daniele Lo Coco, Meritxell B. Cutrona, R. Magnoni, Danilo Pennacchini, B. Pozzi, Genevíève Gowing, Jean‐Pierre Julien, Massimo Tortarolo, Caterina Bendotti · 2005 · Molecular and Cellular Neuroscience
  45. Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis
    Cédric Boucherie, Sabrina Schäfer, Patricia M. Lavand'homme, Jean‐Marie Maloteaux, Emmanuel Hermans · 2009 · Journal of Neuroscience Research
  46. Cognitive Functions and White Matter Tract Damage in Amyotrophic Lateral Sclerosis: A Diffusion Tensor Tractography Study
    Lidia Sarro, Federica Agosta, Elisa Canu, Nilo Riva, Alessandro Cesare Prelle, Massimiliano Copetti, Gianna Carla Riccitelli, Gıancarlo Comı, Massimo Filippi · 2011 · American Journal of Neuroradiology
  47. Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration
    Wilkins, Heather M., Weidling, Ian W., Ji, Yan, Swerdlow, Russell H. · 2017 · Frontiers in Immunology
  48. Microglial Activation in Perinatal Rabbit Brain Induced by Intrauterine Inflammation: Detection with 11C-(R)-PK11195 and Small-Animal PET
    Sujatha Kannan, Fadoua Saadani‐Makki, Otto Muzik, P.K. Chakraborty, Thomas J. Mangner, James J. Janisse, Roberto J. Romero, Diane C. Chugani · 2007 · Journal of Nuclear Medicine
  49. Imbalance of cortical facilitatory and inhibitory circuits underlies hyperexcitability in ALS
    Mehdi A. J. van den Bos, Mana Higashihara, Nimeshan Geevasinga, Parvathi Menon, Matthew C. Kiernan, Steve Vucic · 2018 · Neurology
  50. Structural brain correlates of cognitive and behavioral impairment in MND
    Federica Agosta, Pilar M. Ferraro, Nilo Riva, Edoardo Gioele Spinelli, Adriano Chiò, Elisa Canu, Paola Valsasina, Christian Lunetta, Sandro Iannaccone, Massimiliano Copetti et al. · 2016 · Human Brain Mapping
  51. Integrated magnetic resonance imaging and [11C]‐PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosis
    Mohamad J. Alshikho, Nicole R. Zürcher, Marco L. Loggia, Paul Cernasov, Beverly Reynolds, Olivia Pijanowski, Daniel B. Chonde, David Izquierdo‐Garcia, Caterina Mainero, Ciprian Catana et al. · 2018 · Annals of Neurology
  52. The Peripheral Immune System and Amyotrophic Lateral Sclerosis
    Pamela McCombe, John D. Lee, Trent M. Woodruff, Robert D. Henderson · 2020 · Frontiers in Neurology
  53. Optineurin in amyotrophic lateral sclerosis: Multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms
    Andrea Markovinović, Raffaello Cimbro, Tereza Ljutić, Jasna Križ, Boris Rogelj, Ivana Munitić · 2017 · Progress in Neurobiology
  54. Quantitative Susceptibility MRI to Detect Brain Iron in Amyotrophic Lateral Sclerosis
    Julio Acosta‐Cabronero, Judith Machts, Stefanie Schreiber, Susanne Abdulla, Katja Kollewe, Susanne Petri, Nicola Spotorno, Joern Kaufmann, Hans‐Jochen Heinze, Reinhard Dengler et al. · 2018 · Radiology
  55. Evaluation of Reference Tissue Models for the Analysis of [ 11 C]( R )-PK11195 Studies
    Marc A Kropholler, Ronald Boellaard, Alie Schuitemaker, Hedy Folkersma, Bart N.M. van Berckel, Adriaan A. Lammertsma · 2006 · Journal of Cerebral Blood Flow & Metabolism
  56. Subcortical structures in amyotrophic lateral sclerosis
    Henk‐Jan Westeneng, Esther Verstraete, Renée Walhout, Ruben Schmidt, Jeroen Hendrikse, Jan Herman Veldink, Martijn P. van den Heuvel, Leonard H. van den Berg · 2014 · Neurobiology of Aging
  57. Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis
    Ricarda Menke, Federica Agosta, Julian Großkreutz, Massimo Filippi, Martin R. Turner · 2016 · Neurotherapeutics
  58. Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
    Federica Rizzo, Giulietta Maria Riboldi, Sabrina Salani, Monica Nizzardo, Chiara Simone, Stefania Paola Corti, Eva Hedlund · 2013 · Cellular and Molecular Life Sciences
  59. Cortical hyperexcitability evolves with disease progression in ALS
    Parvathi Menon, Mana Higashihara, Mehdi A. J. van den Bos, Nimeshan Geevasinga, Matthew C. Kiernan, Steve Vucic · 2020 · Annals of Clinical and Translational Neurology
  60. Intrathecal Delivery of Mesenchymal Stromal Cells Protects the Structure of Altered Perineuronal Nets in SOD1 Rats and Amends the Course of ALS
    Serhiy Forostyak, Aleš Homola, Karolína Turnovcová, Pavel Svítil, Pavla Jendelová, Eva Syková · 2014 · Stem Cells
  61. Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis
    Juan Carlos Corona, Luis B. Tovar‐y‐Romo, Ricardo Tapia · 2007 · Expert Opinion on Therapeutic Targets
  62. Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective
    Andrea Malaspina, Fabìola Puentes, Sandra Amor · 2014 · International Immunology
  63. Neuroinflammation in motor neuron disease
    Fumito Endo, Okiru Komine, Koji Yamanaka · 2016 · Clinical and Experimental Neuroimmunology
  64. Phagocytic Roles of Glial Cells in Healthy and Diseased Brains
    Jung, Yeon-Joo, Chung, Won-Suk · 2018 · Biomolecules & Therapeutics
  65. Clinical and Radiological Markers of Extra-Motor Deficits in Amyotrophic Lateral Sclerosis
    Foteini Christidi, Efstratios Karavasilis, Michail Rentzos, Nikolaos Kelekis, Ioannis Evdokimidis, Peter Bede · 2018 · Frontiers in Neurology
  66. Cortical Function in Asymptomatic Carriers and Patients WithC9orf72Amyotrophic Lateral Sclerosis
    Nimeshan Geevasinga, Parvathi Menon, Garth A. Nicholson, Karl Ng, James Howells, Jillian J. Kril, Con Yiannikas, Matthew C. Kiernan, Steve Vucic · 2015 · JAMA Neurology
  67. Magnetic susceptibility in the deep layers of the primary motor cortex in Amyotrophic Lateral Sclerosis
    Mauro Costagli, Graziella Donatelli, Laura Biagi, Elena Caldarazzo Ienco, Gabriele Siciliano, Michela Tosetti, Mirco Cosottini · 2016 · NeuroImage Clinical
  68. New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease
    Laura A. Best, Christine Ghadery, Nicola Pavese, Yen Tai, Antonio P. Strafella · 2019 · Current Neurology and Neuroscience Reports
  69. Altered cortical beta‐band oscillations reflect motor system degeneration in amyotrophic lateral sclerosis
    Malcolm Proudfoot, Gustavo Rohenkohl, Andrew J. Quinn, Giles L. Colclough, Joanne Wuu, Kevin Talbot, Mark W. Woolrich, Michael G Benatar, Anna Christina Nobre, Martin R. Turner · 2016 · Human Brain Mapping
  70. Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology
    Miles S. Lyon, Marlena Wosiski‐Kuhn, Rachel Gillespie, James B. Caress, Carol Milligan · 2018 · Muscle & Nerve
  71. EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases
    Massimo Filippi, Federica Agosta, Sharon Abrahams, Franz Fazekas, Julian Großkreutz, Sanjay Kalra, Jan Kassubek, Vincenzo Silani, Martin R. Turner, Joseph C. Masdeu · 2010 · European Journal of Neurology
  72. Neuroinflammation in motor neuron disease.
    Okiru Komine, Koji Yamanaka · 2015 · Europe PMC (PubMed Central)
  73. A comparison of the high‐affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)‐PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation
    Sriram Venneti, Brian J. Lopresti, Guoji Wang, Susan Slagel, Neale Scott Mason, Chester A. Mathis, Michelle L. Fischer, Niccole J. Larsen, Amanda D. Mortimer, Teresa G. Hastings et al. · 2007 · Journal of Neurochemistry
  74. Downregulated Glia Interplay and Increased miRNA-155 as Promising Markers to Track ALS at an Early Stage
    Carolina Cunha, Catarina Santos, Cátia Gomes, Adelaide Maria Afonso Fernandes, Alexandra Marçal Correia, Ana Maria Sebastião, Ana Rita Vaz, Dora Maria Tuna Oliveira Brites · 2017 · Molecular Neurobiology
  75. The clinical trial landscape in amyotrophic lateral sclerosis—Past, present, and future
    Heike J. Wobst, Korrie L. Mack, Dean G. Brown, Nicholas J. Brandon, James Shorter · 2020 · Medicinal Research Reviews
  76. Plasma Inflammatory Cytokines Are Elevated in ALS
    Rosanna Tortelli, Chiara Zecca, Marco Piccininni, Sara Benmahamed, Maria Teresa Dell’Abate, Maria Rosaria Barulli, Rosa Capozzo, Petronilla Battista, Giancarlo Logroscino · 2020 · Frontiers in Neurology
  77. Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis
    Patrick Weydt, Thomas Mo ̈ller · 2005 · Neuroreport
  78. Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD 1G93A Transgenic Mice and Evaluation of a Sativex®‐like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis
    Miguel Moreno‐Martet, Francisco Espejo‐Porras, Javier Fernández‐Ruíz, Eva de Lago · 2014 · CNS Neuroscience & Therapeutics
  79. Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis
    Steve Vucic, Benjamin C. Cheah, Matthew C. Kiernan · 2009 · Experimental Neurology
  80. Development of a Tracer Kinetic Plasma Input Model for (R)-[11C]PK11195 Brain Studies
    Marc A Kropholler, Ronald Boellaard, Alie Schuitemaker, Bart N.M. van Berckel, Gert Luurtsema, Albert D. Windhorst, Adriaan A. Lammertsma · 2005 · Journal of Cerebral Blood Flow & Metabolism
  81. Neurodegeneration and <scp>NLRP3</scp> inflammasome expression in the anterior thalamus of <scp>SOD1(G93A) ALS</scp> mice
    Debye, Berthold, Schmülling, Lena, Zhou, Lepu, Rune, Gabriele, Beyer, Cordian, Johann, Sonja · 2018 · Brain Pathology
  82. Intrahemispheric and interhemispheric structural network abnormalities in PLS and ALS
    Federica Agosta, Sebastiano Galantucci, Nilo Riva, Adriano Chiò, Stefano Messina, Sandro Iannaccone, Andrea Calvo, Vincenzo Silani, Massimiliano Copetti, Andrea Falini et al. · 2013 · Human Brain Mapping
  83. Structural imaging differences and longitudinal changes in primary lateral sclerosis and amyotrophic lateral sclerosis
    Justin Y. Kwan, Avner Meoded, Laura E. Danielian, Tianxia Wu, Mary Kay Floeter · 2012 · NeuroImage Clinical
  84. Cortical hyperexcitability and disease spread in amyotrophic lateral sclerosis
    Parvathi Menon, Nimeshan Geevasinga, Mehdi A. J. van den Bos, Con Yiannikas, Matthew C. Kiernan, S. Vucic · 2017 · European Journal of Neurology
  85. A data-driven approach links microglia to pathology and prognosis in amyotrophic lateral sclerosis
    Cooper-Knock, Johnathan, Green, Claire, Altschuler, Gabriel, Wei, Wenbin, Bury, Joanna J., Heath, Paul R., Wyles, Matthew, Gelsthorpe, Catherine, Highley, J. Robin, Lorente-Pons, Alejandro et al. · 2017 · Acta Neuropathologica Communications
  86. Examining the Relationship between Head Trauma and Neurodegenerative Disease: A Review of Epidemiology, Pathology and Neuroimaging Techniques
    Mark Sundman · 2014 · Journal of Alzheimer’s Disease & Parkinsonism
  87. NLRP3 Inflammasome Activation in a Transgenic Amyotrophic Lateral Sclerosis Model
    Agnese Gugliandolo, Sabrina Giacoppo, Placido Bramanti, Emanuela Mazzon · 2017 · Inflammation
  88. Discovery of Inhibitors of Microglial Neurotoxicity Acting Through Multiple Mechanisms Using a Stem-Cell-Based Phenotypic Assay
    Susanne Höing, York Rudhard, Peter Reinhardt, Michael Glatza, Martin Stehling, Guangming Wu, Christiane Peiker, Alexander Böcker, Juan A. Parga, Eva Christine Bunk et al. · 2012 · Cell stem cell
  89. The Neuroinflammatory Response in ALS: The Roles of Microglia and T Cells
    Lewis, Coral-Ann, Manning, John, Rossi, Fabio, Krieger, Charles · 2012 · Neurology Research International
  90. Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD
    Hongbo Chen, Mark W. Kankel, Susan C. Su, Steve Han, Dimitry Ofengeim · 2018 · Cell Death and Differentiation
  91. Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
    Tereza Filipi, Zuzana Heřmanová, Jana Turečková, Ondřej Vaňátko, Miroslava Anděrová · 2020 · Journal of Clinical Medicine
  92. Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS
    Martin R. Turner · 2005 · Journal of Neurology Neurosurgery & Psychiatry
  93. The selective anatomical vulnerability of ALS: ‘disease-defining’ and ‘disease-defying’ brain regions
    Peter Bede, Parameswaran Mahadeva Iyer, Christina Schuster, Marwa Elamin, Russell Lewis McLaughlin, Kevin Patrick Kenna, Orla M. Hardiman · 2016 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  94. The dual roles of immunity in ALS: Injury overrides protection
    Benjamin J. Murdock, Diane E. Bender, Benjamin M. Segal, Eva L. Feldman · 2015 · Neurobiology of Disease
  95. Neuroimaging in amyotrophic lateral sclerosis: current and emerging uses
    Federica Agosta, Edoardo Gioele Spinelli, Massimo Filippi · 2018 · Expert Review of Neurotherapeutics
  96. Kinetic evaluation in nonhuman primates of two new PET ligands for peripheral benzodiazepine receptors in brain
    Masao Imaizumi, Emmanuelle Briard, Sami S. Zoghbi, Jonathan P. Gourley, Jinsoo S. Hong, John L. Musachio, Robert L. Gladding, Victor William Pike, Robert B. Innis, Masahiro Fujita · 2007 · Synapse
  97. Regional thalamic MRI as a marker of widespread cortical pathology and progressive frontotemporal involvement in amyotrophic lateral sclerosis
    Sicong Tu, Ricarda Menke, Kevin Talbot, Matthew C. Kiernan, Martin R. Turner · 2018 · Journal of Neurology Neurosurgery & Psychiatry
  98. The role of inflammation in neurodegeneration: novel insights into the role of the immune system in C9orf72 HRE-mediated ALS/FTD
    Pegah Masrori, Jimmy Beckers, Helena Gossye, Philip Van Damme · 2022 · Molecular Neurodegeneration
  99. Subcortical motor plasticity in patients with sporadic ALS: An fMRI study
    Alessandro Tessitore, Fabrizio Esposito, Maria Rosaria Monsurrò, S. Graziano, Daniela Panza, Antonio Russo, Raffaella Migliaccio, Francesca Luisa Conforti, R. Morrone, Aldo Quattrone et al. · 2006 · Brain Research Bulletin
  100. CHI3L1 and CHI3L2 overexpression in motor cortex and spinal cord of sALS patients
    Cristina Sanfilippo, Anna Longo, Francesca Lazzara, Daniela Cambria, Gisella Distefano, M. Palumbo, Antonio Cantarella, Lucia Malaguarnera, Michelino Di Rosa · 2017 · Molecular and Cellular Neuroscience